Taiwania Capital Management Corporation

What Taiwania Capital Management Corporation does

Taiwania Capital Management Corporation is a Taipei-headquartered venture capital firm founded in 2017 that invests in technology companies across Asia, North America, and Europe. The firm manages multiple investment vehicles, including the Taiwania Capital flagship fund, the TaiAx Life Science Fund L.P. — a joint venture with Axil Capital launched in August 2024 targeting life sciences in Asia-Pacific — and the Taiwania Hive Ventures sub-brand for seed-stage deals. It maintains a US subsidiary, Taiwania Capital Management USA, Inc., based in Santa Clara, California, supporting North American deal flow and portfolio support.

The firm invests across seed to pre-IPO stages in sectors spanning biotech and life sciences, AI infrastructure, defense technology, semiconductors, digital health, enterprise software, drones, and advanced manufacturing (including femtosecond lasers and supercapacitors). Notable portfolio activity includes HavocAI ($85M defense autonomy round, October 2025), Skeleton Technologies (€33M pre-IPO first close, May 2026), Alcatraz AI ($50M Series B, April 2026), Supernova ($9.2M Series A, October 2025), Health2Sync ($20M Series C, March 2025), DataPelago ($47M, October 2024), Opsera ($20M Series B, April 2025), Orqa (€12.7M Series A, March 2026), and Decube ($3M seed, May 2026). Co-investors span tier-1 institutional and strategic names including B Capital, In-Q-Tel, Lockheed Martin Ventures, Hanwha, Lightspeed Venture Partners, Y Combinator, Qualcomm Ventures, Prosperity7 Ventures (Aramco), Wistron, Pegatron, and Eclipse.

Taiwania Capital's business model is classic venture capital economics: capital deployment from limited partners into portfolio companies, with revenue derived from management fees on committed capital and carried interest on realized exits. The firm does not disclose AUM, fee rates, or revenue. Leadership comprises CEO David Weng and Managing Partner Michael Huang. The firm is privately held with no parent company and 11–50 employees.

Name

Taiwania Capital Management Corporation

Legal name

Taiwania Capital Management Corporation

Website

https://en.taiwaniacapital.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

Taiwania Capital Management Corporation is a Taipei-based venture capital firm founded in 2017 that invests across stages and geographies in biotech, AI infrastructure, defense technology, semiconductors, and enterprise software. It serves technology startups globally through its flagship fund, the TaiAx Life Science JV with Axil Capital, and a US subsidiary in Santa Clara.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

Portfolio Management and Investment Advice (52394), Securities, Commodity Contracts, and Other Financial Investments and Related Activities (523)

SIC

Investment Advice (6282), Security Brokers, Dealers & Flotation Companies (6211)

akta.pro primary industry

Corporate Strategic Real Assets & Infrastructure Venture Investing (FSANAHAN)

akta.pro secondary industry

Corporate Finance & Capital Advisory (BPAHADAB)

Keywords

• Venture capital funding
• Technology startup investment
• Growth equity capital
• Biotech investment funds
• Cross border venture capital

Headquarters

HQ city

Taipei

HQ country

Taiwan

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Investment Management and Fund Returns: Taiwania Capital generates returns through investment in technology startups across multiple sectors. As a VC firm, they manage funds and earn returns through equity appreciation, exits via IPO or acquisition, and management fees from their investment funds.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Taiwania Capital Management Corporation is a Taiwan-based venture capital firm that manages investment funds and deploys capital into early- to growth-stage technology startups across sectors including biotech, AI, defense technology, semiconductors, and advanced manufacturing. The firm links Taiwan's technology ecosystem with international investors and markets, and operates funds such as the TaiAx Life Science Fund L.P., a joint venture with Axil Capital. Its portfolio spans over 100 companies across Taiwan, the US, Europe, and the Asia-Pacific region.

Product overview

Taiwania Capital Management Corporation is a venture capital firm that manages multiple investment funds, including Taiwania Capital funds and the TaiAx Life Science Fund L.P. The firm provides investment capital to technology startups across sectors including biotech, AI infrastructure, defense technology, and advanced manufacturing. Rather than offering a unified software product, the company operates as a fund manager connecting capital with innovative companies, with its portfolio spanning over 80 companies including healthcare platforms, autonomous systems developers, semiconductor firms, and enterprise AI solutions providers.

Differentiator

Problem solved

Functional benefit

Products and services

• TaiAx Life Science Fund L.P. Joint venture investment fund jointly launched by Taiwania Capital and Axil Capital, targeting life science and biotechnology investments in Taiwan and the Asia-Pacific region. Designed to support biotech and pharmaceutical companies pursuing regulatory approval in the US and other major markets, creating a diversified investor base anchored in key global markets.

Quantifiable outcome

• Multiple successful funding rounds for portfolio companies exceeding $100M in aggregate
• +2 more outcomes

Named customers11 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• WI Harper Group: Pioneer Taiwan-US cross-border venture capital firm investing in early-to-growth-stage technology companies. Directly comparable to Taiwania in cross-border bridge strategy, sector focus on biotech/healthcare and deep tech, and dual Asia-US presence.
• CDIB Capital Group: Taiwan-based venture capital and private equity firm with broad technology and biotech mandates. Comparable to Taiwania as a Taiwanese institutional VC deploying capital across the technology stack and supporting portfolio companies' cross-border expansion.
• Hotung Venture Capital: Taiwan-domiciled venture capital firm investing in semiconductor, biotech, and digital technology startups. Highly comparable to Taiwania in Taiwan-anchored, multi-vertical technology deployment and emphasis on early-stage Taiwanese innovation.
• AppWorks: Taiwan's largest startup accelerator and early-stage VC fund, investing in AI, blockchain, and Southeast Asia tech founders. Comparable to Taiwania in Taiwan-headquartered early-stage tech investing with regional (APAC) expansion mandate.
• Darwin Ventures: Taiwan-based venture capital firm focused on AI, semiconductors, and digital health. Comparable to Taiwania in Taiwan-based multi-vertical technology investing, particularly in semiconductor-related deep tech and digital health.
• IDG Capital: One of the largest global venture capital firms with deep Asia presence and US-China cross-border operations. Comparable to Taiwania in cross-border tech investing across consumer, enterprise, biotech, and deep tech.
• Wavemaker Partners: US-Asia early-stage venture capital firm investing in enterprise, deep tech, and healthtech. Comparable to Taiwania in cross-border US-Asia deployment model and sector focus on enterprise and deep technology.
• 500 Global: Global venture capital firm and accelerator with extensive APAC operations and emerging-market focus. Comparable to Taiwania as a co-investor across Taiwania-led rounds (e.g., Decube) and as a global multi-stage VC targeting similar geographies.
• Plug and Play Tech Center: Global startup accelerator and venture investor with corporate-partner network spanning multiple verticals. Comparable to Taiwania in multi-sector tech investing through corporate partnerships and accelerator-style sourcing.
• Golden Gate Ventures: Early-stage venture capital firm focused on Southeast Asia technology startups with cross-border operations. Comparable to Taiwania as an Asia-headquartered multi-stage VC with cross-border mandates and a broad sector remit including enterprise and consumer technology.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/taiwaniacapital

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments124 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Taiwania Capital Management Corporation